LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220K954. A total of 4 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,625,000 | -92.7% | 36,100 | -89.6% | 0.00% | -85.7% |
| Q4 2019 | $36,043,000 | +4.8% | 345,600 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $34,401,000 | +323.0% | 345,600 | +434.2% | 0.01% | +250.0% |
| Q1 2019 | $8,133,000 | -76.6% | 64,700 | -74.7% | 0.00% | -75.0% |
| Q4 2018 | $34,685,000 | +2175.9% | 255,600 | +1604.0% | 0.01% | – |
| Q4 2016 | $1,524,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 38,000 | $3,783,000 | 0.03% |
| SIMPLEX TRADING, LLC | 265 | $2,637,000 | 0.01% |
| JPMORGAN CHASE & CO | 345,600 | $34,401,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |